W J Hueston
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
W J Hueston has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Arch G. Mainous
Department of Community Health and Family Medicine, University of Florida
12 shared publications A G Mainous
2 shared publicationsM E Evans
2 shared publications- M M Love
Department of Family Practice, University of Kentucky, Lexington 40536-0284, USA
2 shared publications J Mercuri
1 shared publicationJ R Clark
1 shared publication
Latest Publications
- 1 June 2001
- Vol. 33 (6) , 459-65
Female and underrepresented minority faculty in academic departments of family medicine: are women and minorities better off in family medicine?
Several studies have shown that the percentage of women represented in senior academic positions at US medical schools is lower than the percentage of men in senior positions. Similarly, the percentage of minority faculty members represented in senior academic positions is lower than that of their majority counterparts. This study assessed whether these findings were also present in departments of family medicine and identified any factors related to the institution or department that favored academic success for women and minorities. Data regarding faculty workforce composition, including faculty rank and rank for women and underrepresented minorities, were extracted from a comprehensive survey of departments of family medicine at US allopathic medical schools. The data are based on faculty workforce in 1997 and include responses from 58 (51%) of all schools with a department of family medicine. Faculty in departments of family medicine were more likely to be female (41% versus 25%) and an underrepresented minority (9% versus 4%), compared with all academic medicine disciplines. However, women in full-time positions were less likely than men, and minorities were less likely than nonminorities, to be either an associate or full professor. We could find no institutional or departmental characteristics that were associated with academic success for women or minority faculty members. While women and underrepresented minorities are more common to the faculty workforce in family medicine, members of both of these groups are not well represented in senior faculty ranks.
- 1 June 2001
- Vol. 33 (6) , 459-65
Female and underrepresented minority faculty in academic departments of family medicine: are women and minorities better off in family medicine?
Several studies have shown that the percentage of women represented in senior academic positions at US medical schools is lower than the percentage of men in senior positions. Similarly, the percentage of minority faculty members represented in senior academic positions is lower than that of their majority counterparts. This study assessed whether these findings were also present in departments of family medicine and identified any factors related to the institution or department that favored academic success for women and minorities. Data regarding faculty workforce composition, including faculty rank and rank for women and underrepresented minorities, were extracted from a comprehensive survey of departments of family medicine at US allopathic medical schools. The data are based on faculty workforce in 1997 and include responses from 58 (51%) of all schools with a department of family medicine. Faculty in departments of family medicine were more likely to be female (41% versus 25%) and an underrepresented minority (9% versus 4%), compared with all academic medicine disciplines. However, women in full-time positions were less likely than men, and minorities were less likely than nonminorities, to be either an associate or full professor. We could find no institutional or departmental characteristics that were associated with academic success for women or minority faculty members. While women and underrepresented minorities are more common to the faculty workforce in family medicine, members of both of these groups are not well represented in senior faculty ranks.
- 1 January 2000
- Vol. 32 (1) , 22-9
An evaluation of statewide strategies to reduce antibiotic overuse.
The rapid increase of antibiotic resistance poses a significant threat to human health. Overuse of antibiotics has been linked to rates of antibiotic resistance. This study assessed the utility of two common interventions--1) practice profiling and feedback and 2) patient education materials--implemented to decrease antibiotic prescribing for pediatric upper respiratory infections (URIs). Based on Medicaid regions in Kentucky, primary care physicians managing pediatric respiratory infections in Medicaid were randomized into four groups. Groups received either 1) performance feedback only, 2) patient education materials only, 3) both feedback and education materials, or 4) no intervention. Participating physicians had their antibiotic prescribing assessed for the period of July 1, 1996, to November 30, 1997, with an intervention in June 1997. The study included 216 physicians and 124,092 episodes of care. All groups increased in proportion of episodes with antibiotics between the pre-intervention and post-intervention periods. Prescribing in the patient education group and the patient education and feedback group increased at a significantly lower rate than in the control group. Physicians did not change their coding of illness to justify antibiotics after the intervention, and there was no significant generalization of effect of the pediatric intervention on prescribing for adult URIs. These interventions demonstrate little if any impact on promoting appropriate antibiotic prescribing. Antibiotic prescribing for viral respiratory infections continues to increase, suggesting concomitant increases in antibiotic resistance.
- 1 January 2000
- Vol. 32 (1) , 22-9
An evaluation of statewide strategies to reduce antibiotic overuse.
The rapid increase of antibiotic resistance poses a significant threat to human health. Overuse of antibiotics has been linked to rates of antibiotic resistance. This study assessed the utility of two common interventions--1) practice profiling and feedback and 2) patient education materials--implemented to decrease antibiotic prescribing for pediatric upper respiratory infections (URIs). Based on Medicaid regions in Kentucky, primary care physicians managing pediatric respiratory infections in Medicaid were randomized into four groups. Groups received either 1) performance feedback only, 2) patient education materials only, 3) both feedback and education materials, or 4) no intervention. Participating physicians had their antibiotic prescribing assessed for the period of July 1, 1996, to November 30, 1997, with an intervention in June 1997. The study included 216 physicians and 124,092 episodes of care. All groups increased in proportion of episodes with antibiotics between the pre-intervention and post-intervention periods. Prescribing in the patient education group and the patient education and feedback group increased at a significantly lower rate than in the control group. Physicians did not change their coding of illness to justify antibiotics after the intervention, and there was no significant generalization of effect of the pediatric intervention on prescribing for adult URIs. These interventions demonstrate little if any impact on promoting appropriate antibiotic prescribing. Antibiotic prescribing for viral respiratory infections continues to increase, suggesting concomitant increases in antibiotic resistance.
- 1 April 1998
- Vol. 152 (4) , 349-52
Antibiotics for colds in children: who are the high prescribers?
To examine physician characteristics associated with being a high prescriber of antibiotics for pediatric upper respiratory tract infections (URIs). Analysis of 34624 episodes of care for URIs in children (younger than 18 years) in the Kentucky Medicaid program from July 1, 1995, to June 30, 1996. Primary care physicians with at least 25 episodes of care (n=205). The proportion of patients with URIs receiving antibiotics stratified the sample into low (< or =25th percentile) and high (> or =75th percentile) antibiotic prescribers. Bivariate analyses were computed comparing the high and low prescribers. A logistic regression model was computed for likelihood of being a high prescriber by number of URI episodes, proportion of patients receiving antibiotics that were broad spectrum, years since medical school graduation, physician gender, rural/urban practice, and specialty. The high prescriber group (n=52) included data from 11899 episodes of care, with a mean prescribing rate of 80%. The low prescriber group (n=55) included data from 5396 episodes, with a mean prescribing rate of 16%. High prescribers were significantly more years away from medical school graduation (27 vs 19 years; P<.001) and had managed significantly more URI episodes than low prescribers (229 vs 98; P=.001). In the logistic regression, compared with pediatricians, the odds ratios of being a high prescriber were 409 (95% confidence interval [CI], 29-7276) for family practitioners and 318 (95% CI, 17-6125) for other primary care physicians. With the rise of antibiotic-resistant bacteria, more focused training regarding treatment of URIs is warranted in residency and in continuing medical education forums.
- 1 April 1998
- Vol. 152 (4) , 349-52
Antibiotics for colds in children: who are the high prescribers?
To examine physician characteristics associated with being a high prescriber of antibiotics for pediatric upper respiratory tract infections (URIs). Analysis of 34624 episodes of care for URIs in children (younger than 18 years) in the Kentucky Medicaid program from July 1, 1995, to June 30, 1996. Primary care physicians with at least 25 episodes of care (n=205). The proportion of patients with URIs receiving antibiotics stratified the sample into low (< or =25th percentile) and high (> or =75th percentile) antibiotic prescribers. Bivariate analyses were computed comparing the high and low prescribers. A logistic regression model was computed for likelihood of being a high prescriber by number of URI episodes, proportion of patients receiving antibiotics that were broad spectrum, years since medical school graduation, physician gender, rural/urban practice, and specialty. The high prescriber group (n=52) included data from 11899 episodes of care, with a mean prescribing rate of 80%. The low prescriber group (n=55) included data from 5396 episodes, with a mean prescribing rate of 16%. High prescribers were significantly more years away from medical school graduation (27 vs 19 years; P<.001) and had managed significantly more URI episodes than low prescribers (229 vs 98; P=.001). In the logistic regression, compared with pediatricians, the odds ratios of being a high prescriber were 409 (95% confidence interval [CI], 29-7276) for family practitioners and 318 (95% CI, 17-6125) for other primary care physicians. With the rise of antibiotic-resistant bacteria, more focused training regarding treatment of URIs is warranted in residency and in continuing medical education forums.
- 15 March 1998
- Vol. 57 (6) , 1270-6, 1281
Acute bronchitis.
Acute bronchitis is a lower respiratory tract infection that causes reversible bronchial inflammation. In up to 95 percent of cases, the cause, is viral. While antibiotics are often prescribed for patients with acute bronchitis, little evidence shows that these agents provide significant symptomatic relief or shorten the course of the illness. In a few small studies, bronchodilators such as albuterol have been found to relieve some symptoms of acute bronchitis. Increased attention is being given to the role of Chlamydia species in acute bronchitis and adult-onset asthma. Studies in progress may help to clarify the importance of these organisms in acute bronchitis and to determine whether early treatment can prevent or ameliorate asthma.
- 15 March 1998
- Vol. 57 (6) , 1270-6, 1281
Acute bronchitis.
Acute bronchitis is a lower respiratory tract infection that causes reversible bronchial inflammation. In up to 95 percent of cases, the cause, is viral. While antibiotics are often prescribed for patients with acute bronchitis, little evidence shows that these agents provide significant symptomatic relief or shorten the course of the illness. In a few small studies, bronchodilators such as albuterol have been found to relieve some symptoms of acute bronchitis. Increased attention is being given to the role of Chlamydia species in acute bronchitis and adult-onset asthma. Studies in progress may help to clarify the importance of these organisms in acute bronchitis and to determine whether early treatment can prevent or ameliorate asthma.
- 1 February 1998
- Vol. 46 (2) , 142-6
Patterns of antibiotic-resistant Streptococcus pneumoniae in children in a day-care setting.
Streptococcus pneumoniae is one of the primary causes of illness and death among young children, and evidence suggests that the prevalence of antibiotic-resistant S pneumoniae is increasing. The purpose of this study was to investigate the prevalence of antibiotic-resistant S pneumoniae in a sample of children in day-care facilities in a region that includes both rural and urban communities. Nasopharyngeal cultures were obtained from 104 children in eight day-care centers located in rural and urban central Kentucky in April and May, 1997. Thirty-five of the children produced isolates positive for S pneumoniae. Each isolate was tested for susceptibility to penicillin, trimethoprim-sulfamethoxazole, erythromycin, tetracycline, vancomycin, and cefotaxime. Of the children with S pneumoniae isolates, 54% had isolates that were resistant to penicillin and 40% that were resistant to trimethoprim-sulfamethoxazole. Twenty-one (60%) of the isolates had resistance to at least one of the six tested antimicrobials, with 15 (43%) having resistance to more than one of the antimicrobials. The mean age of children with isolates resistant to penicillin was significantly less (2.7 + 1.6) than those with penicillin-susceptible isolates (3.7 + 1.1, P = .02). There was no relation between resistance and rural or urban day-care location. A substantial proportion of S pneumoniae isolates in young children are resistant to antibiotics. Limiting the effect of S pneumoniae drug resistance may require a reexamination of outpatient treatment strategies for childhood respiratory tract infections.
- 1 February 1998
- Vol. 46 (2) , 142-6
Patterns of antibiotic-resistant Streptococcus pneumoniae in children in a day-care setting.
Streptococcus pneumoniae is one of the primary causes of illness and death among young children, and evidence suggests that the prevalence of antibiotic-resistant S pneumoniae is increasing. The purpose of this study was to investigate the prevalence of antibiotic-resistant S pneumoniae in a sample of children in day-care facilities in a region that includes both rural and urban communities. Nasopharyngeal cultures were obtained from 104 children in eight day-care centers located in rural and urban central Kentucky in April and May, 1997. Thirty-five of the children produced isolates positive for S pneumoniae. Each isolate was tested for susceptibility to penicillin, trimethoprim-sulfamethoxazole, erythromycin, tetracycline, vancomycin, and cefotaxime. Of the children with S pneumoniae isolates, 54% had isolates that were resistant to penicillin and 40% that were resistant to trimethoprim-sulfamethoxazole. Twenty-one (60%) of the isolates had resistance to at least one of the six tested antimicrobials, with 15 (43%) having resistance to more than one of the antimicrobials. The mean age of children with isolates resistant to penicillin was significantly less (2.7 + 1.6) than those with penicillin-susceptible isolates (3.7 + 1.1, P = .02). There was no relation between resistance and rural or urban day-care location. A substantial proportion of S pneumoniae isolates in young children are resistant to antibiotics. Limiting the effect of S pneumoniae drug resistance may require a reexamination of outpatient treatment strategies for childhood respiratory tract infections.
- 1 September 1997
- Vol. 29 (8) , 568-71
Using other people's data: the ins and outs of secondary data analysis.
A variety of types of data ranging from administrative data sets to large-scale surveys have been collected for one purpose but can be accessed and used to address new questions of relevance to primary care. For many research questions, primary data collection isn't necessary because the data already exists. Although relatively few researchers consider analyzing existing data sets, there are a variety of advantages to secondary analysis. This paper introduces the practical aspects of performing secondary analysis. We review the types of questions that can addressed, where and how to access data, and the steps involved in preparing data for analysis.
- 1 September 1997
- Vol. 29 (8) , 568-71
Using other people's data: the ins and outs of secondary data analysis.
A variety of types of data ranging from administrative data sets to large-scale surveys have been collected for one purpose but can be accessed and used to address new questions of relevance to primary care. For many research questions, primary data collection isn't necessary because the data already exists. Although relatively few researchers consider analyzing existing data sets, there are a variety of advantages to secondary analysis. This paper introduces the practical aspects of performing secondary analysis. We review the types of questions that can addressed, where and how to access data, and the steps involved in preparing data for analysis.
- 1 September 1997
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 72 (9) , 804-6
A comparison of the numbers of pharmaceutical advertising pages in family medicine research journals and journals in other medical disciplines
PURPOSE: To determine whether declines in pharmaceutical industry advertising have been greater for family medicine research journals than for journals in other disciplines. METHOD: Three family medicine research journals and eight randomly selected journals in other disciplines were chosen for this study. The number of advertising pages from the first issue of each journal from 1990 through 1995 were calculated by manually counting every journal page that contained all or part of an advertisement for a pharmaceutical product. Data were compared using Student's t-test. RESULTS: Overall, the mean number of pages of pharmaceutical advertising in all of the journals fell 41%, from 34 pages in 1990-1991 to 21 pages in 1994-1995. For the three family medicine journals the drop over the same six-year period was 55% (from 30 to 14, p = .01), compared with a 35% drop for the eight other journals (from 36 to 23, p < .001). CONCLUSION: Although advertising in medical research journals has dropped in all disciplines, it would appear that the decline for family medicine journals has been disproportionately large. The potential effect of this decline for the discipline of family medicine is a decrease in the outlets and opportunities for the publication of new knowledge.
- 1 September 1997
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 72 (9) , 804-6
A comparison of the numbers of pharmaceutical advertising pages in family medicine research journals and journals in other medical disciplines
PURPOSE: To determine whether declines in pharmaceutical industry advertising have been greater for family medicine research journals than for journals in other disciplines. METHOD: Three family medicine research journals and eight randomly selected journals in other disciplines were chosen for this study. The number of advertising pages from the first issue of each journal from 1990 through 1995 were calculated by manually counting every journal page that contained all or part of an advertisement for a pharmaceutical product. Data were compared using Student's t-test. RESULTS: Overall, the mean number of pages of pharmaceutical advertising in all of the journals fell 41%, from 34 pages in 1990-1991 to 21 pages in 1994-1995. For the three family medicine journals the drop over the same six-year period was 55% (from 30 to 14, p = .01), compared with a 35% drop for the eight other journals (from 36 to 23, p < .001). CONCLUSION: Although advertising in medical research journals has dropped in all disciplines, it would appear that the decline for family medicine journals has been disproportionately large. The potential effect of this decline for the discipline of family medicine is a decrease in the outlets and opportunities for the publication of new knowledge.
- 1 June 1997
- Vol. 44 (6) , 572-7
Evaluation and treatment of respiratory infections: does managed care make a difference?
Primary care physicians frequently use antibiotics for nonindicated conditions and conditions for which antibiotics have not been shown to be effective. The intention of this study was to determine whether shifting the costs from the insurer to physicians in a staff model health maintenance organization (HMO) influenced antibiotic prescribing. A random sample of patients in whom upper respiratory infections (URIs) (n = 334) or acute bronchitis (n = 218) were diagnosed within a 12-month period was selected from a large multispecialty group practice whose population was predominantly fee-for-service (FFS) and from a staff model HMO. Detailed chart reviews were performed to verify the diagnosis and note secondary diagnoses, identify whether an antibiotic or other medication was prescribed, assess whether diagnostic testing was performed, and determine the specialty of the clinician. After excluding patients seen with sinusitis, otitis media, or streptococcal pharyngitis, 334 patients with URIs and 218 patients with acute bronchitis remained for analysis. For URIs, antibiotic prescribing was higher in the HMO population than in the FFS group (31% vs 20%, P = .02). In patients with acute bronchitis, HMO patients were also more likely to have an antibiotic prescribed, but the difference was not statistically significant (82% vs 73%, P = .11). Further analyses showed that while HMO physicians were more likely to prescribe antibiotics, they were less likely to prescribe other medications for acute bronchitis or use diagnostic tests for evaluation of patients with URIs or bronchitis. Shifting costs from insurer to physicians through managed care appears to reduce diagnostic testing for URIs and acute bronchitis, but does not decrease excessive use of antibiotics and may actually increase antibiotic use for URIs.
- 1 June 1997
- Vol. 44 (6) , 572-7
Evaluation and treatment of respiratory infections: does managed care make a difference?
Primary care physicians frequently use antibiotics for nonindicated conditions and conditions for which antibiotics have not been shown to be effective. The intention of this study was to determine whether shifting the costs from the insurer to physicians in a staff model health maintenance organization (HMO) influenced antibiotic prescribing. A random sample of patients in whom upper respiratory infections (URIs) (n = 334) or acute bronchitis (n = 218) were diagnosed within a 12-month period was selected from a large multispecialty group practice whose population was predominantly fee-for-service (FFS) and from a staff model HMO. Detailed chart reviews were performed to verify the diagnosis and note secondary diagnoses, identify whether an antibiotic or other medication was prescribed, assess whether diagnostic testing was performed, and determine the specialty of the clinician. After excluding patients seen with sinusitis, otitis media, or streptococcal pharyngitis, 334 patients with URIs and 218 patients with acute bronchitis remained for analysis. For URIs, antibiotic prescribing was higher in the HMO population than in the FFS group (31% vs 20%, P = .02). In patients with acute bronchitis, HMO patients were also more likely to have an antibiotic prescribed, but the difference was not statistically significant (82% vs 73%, P = .11). Further analyses showed that while HMO physicians were more likely to prescribe antibiotics, they were less likely to prescribe other medications for acute bronchitis or use diagnostic tests for evaluation of patients with URIs or bronchitis. Shifting costs from insurer to physicians through managed care appears to reduce diagnostic testing for URIs and acute bronchitis, but does not decrease excessive use of antibiotics and may actually increase antibiotic use for URIs.
- 1 August 1996
- Vol. 43 (2) , 171-6
Family medicine research in the community setting: what can we learn from successful researchers?
There is little information describing family physician researchers who work outside academic medical centers. This report describes the motivating factors and resources used by community residency faculty and nonfaculty family physicians who perform research. We sent a questionnaire to community residency faculty and nonfaculty family physicians who published at least one paper in the family medicine literature from 1992 through 1994. The survey focused on previous research experience, training, and collaboration with university colleagues, and included an open-ended question about motivations and obstacles to research. The majority (60%) of community faculty and nonfaculty family physicians surveyed reported previous research experience on the undergraduate, medical school, or residency level. Research training received during residency was evaluated as poor. Sixty-nine percent of the respondents reported being successful at acquiring research funding, and 60% reported receiving funding from foundations. Reported keys to success included mentoring, a supportive infrastructure, and an inherent enjoyment in doing research. These factors did not differ between community residency faculty and nonfaculty physicians. For community-based family physicians, success at conducting and publishing research is enhanced by the availability of mentoring, support from local or national foundations, and previous research experience. Respondents identified research training during residency as one area that needs improvement.
- 1 August 1996
- Vol. 43 (2) , 171-6
Family medicine research in the community setting: what can we learn from successful researchers?
There is little information describing family physician researchers who work outside academic medical centers. This report describes the motivating factors and resources used by community residency faculty and nonfaculty family physicians who perform research. We sent a questionnaire to community residency faculty and nonfaculty family physicians who published at least one paper in the family medicine literature from 1992 through 1994. The survey focused on previous research experience, training, and collaboration with university colleagues, and included an open-ended question about motivations and obstacles to research. The majority (60%) of community faculty and nonfaculty family physicians surveyed reported previous research experience on the undergraduate, medical school, or residency level. Research training received during residency was evaluated as poor. Sixty-nine percent of the respondents reported being successful at acquiring research funding, and 60% reported receiving funding from foundations. Reported keys to success included mentoring, a supportive infrastructure, and an inherent enjoyment in doing research. These factors did not differ between community residency faculty and nonfaculty physicians. For community-based family physicians, success at conducting and publishing research is enhanced by the availability of mentoring, support from local or national foundations, and previous research experience. Respondents identified research training during residency as one area that needs improvement.
- 1 April 1996
- Vol. 42 (4) , 357-61
Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold.
Symptomatic treatment is the only recommended therapy for the uncomplicated "common cold." The purpose of this study was to examine the use of antibiotics and other prescription medications for the common cold in a Medicaid population seen in ambulatory care settings. A cross-sectional sample of Kentucky Medicaid claims from July 1, 1993, through June 30, 1994, was analyzed. Subjects were patients seen in an ambulatory setting for the common cold, defined as acute nasopharyngitis. A total of 1439 individuals were seen for 2171 separate outpatient and emergency department encounters for the common cold. Outpatient visits accounted for 99% (2144) of the encounters. Patients in 35% (752) of the encounters did not fill a prescription for medication, 6% (129) filled a prescription for an antihistamine or other symptomatic medication, and 60% (1290) filled a prescription for an antibiotic for the common cold. Nineteen different antibiotics, 54% of which were amoxicillin, were prescribed for the common cold. Less than 2% of the encounters had a secondary diagnosis of either acute sinusitis or otitis media. These encounters were not more likely than the total sample to receive antibiotics. Adults were more likely than children to receive an antibiotic (P<.001), and urban physicians were more likely than rural physicians to prescribe antibiotics (P=.02). A conservative estimate of the annual cost of antibiotic prescribing for the common cold in the United States was $37.5 million. A majority of persons receiving medical care for the common cold are given prescriptions for an unnecessary antibiotic. Unchecked, this practice may lead to greater antibiotic resistance and unnecessary use of health care resources. Future research should focus on the ability to institute behavioral changes for treatment of the common cold in both closed systems (eg, managed care) and open systems (eg, general community of physicians).
- 1 April 1996
- Vol. 42 (4) , 357-61
Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold.
Symptomatic treatment is the only recommended therapy for the uncomplicated "common cold." The purpose of this study was to examine the use of antibiotics and other prescription medications for the common cold in a Medicaid population seen in ambulatory care settings. A cross-sectional sample of Kentucky Medicaid claims from July 1, 1993, through June 30, 1994, was analyzed. Subjects were patients seen in an ambulatory setting for the common cold, defined as acute nasopharyngitis. A total of 1439 individuals were seen for 2171 separate outpatient and emergency department encounters for the common cold. Outpatient visits accounted for 99% (2144) of the encounters. Patients in 35% (752) of the encounters did not fill a prescription for medication, 6% (129) filled a prescription for an antihistamine or other symptomatic medication, and 60% (1290) filled a prescription for an antibiotic for the common cold. Nineteen different antibiotics, 54% of which were amoxicillin, were prescribed for the common cold. Less than 2% of the encounters had a secondary diagnosis of either acute sinusitis or otitis media. These encounters were not more likely than the total sample to receive antibiotics. Adults were more likely than children to receive an antibiotic (P<.001), and urban physicians were more likely than rural physicians to prescribe antibiotics (P=.02). A conservative estimate of the annual cost of antibiotic prescribing for the common cold in the United States was $37.5 million. A majority of persons receiving medical care for the common cold are given prescriptions for an unnecessary antibiotic. Unchecked, this practice may lead to greater antibiotic resistance and unnecessary use of health care resources. Future research should focus on the ability to institute behavioral changes for treatment of the common cold in both closed systems (eg, managed care) and open systems (eg, general community of physicians).